当前位置:首页 - 行情中心 - 安旭生物(688075) - 财务分析 - 现金流量表

安旭生物

(688075)

  

流通市值:37.34亿  总市值:37.34亿
流通股本:1.27亿   总股本:1.27亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金181,090,542.3887,427,387.52429,021,922.21339,734,120.67
  收到的税费返还14,155,772.956,840,874.833,281,601.2532,717,313.76
  收到其他与经营活动有关的现金17,279,607.0512,830,319.9222,072,346.7644,642,619.29
  经营活动现金流入小计212,525,922.38107,098,582.24484,375,870.22417,094,053.72
  购买商品、接受劳务支付的现金146,389,048.2761,366,917.02228,414,808.18201,488,386.32
  支付给职工以及为职工支付的现金69,121,797.3940,178,299.9114,677,662.61112,547,131.15
  支付的各项税费16,940,837.766,901,370.9549,642,119.6353,857,043.97
  支付其他与经营活动有关的现金15,597,095.91,726,670.08101,048,445.3548,019,054.26
  经营活动现金流出的平衡项目0.010.0100
  经营活动现金流出小计248,048,779.33110,173,257.96493,783,035.77415,911,615.7
  经营活动产生的现金流量净额-35,522,856.95-3,074,675.72-9,407,165.551,182,438.02
二、投资活动产生的现金流量:
  收回投资收到的现金5,539,171,798.172,935,441,427.8910,558,878,9068,804,098,122.99
  取得投资收益收到的现金150,555,055.05109,593,880.14131,793,900.721,670,686.03
  处置固定资产、无形资产和其他长期资产收回的现金净额748-334,315.58-
  投资活动现金流入小计5,689,727,601.223,045,035,308.0310,691,007,122.288,825,768,809.02
  购建固定资产、无形资产和其他长期资产支付的现金19,580,99910,784,74995,590,515.6454,144,956.11
  投资支付的现金5,706,151,579.452,968,150,279.4510,319,622,6568,942,858,961.91
  取得子公司及其他营业单位支付的现金-1,511,385.63---
  支付其他与投资活动有关的现金--157,902,420.28362,910
  投资活动现金流出小计5,724,221,192.822,978,935,028.4510,573,115,591.928,997,366,828.02
  投资活动产生的现金流量净额-34,493,591.666,100,279.58117,891,530.36-171,598,019
三、筹资活动产生的现金流量:
  偿还债务支付的现金--280,000-
  分配股利、利润或偿付利息支付的现金--101,667,248.27106,474,954.59
  支付其他与筹资活动有关的现金24,325,773.2-4,062,975.58-
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计24,325,773.2-106,010,223.85106,474,954.59
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-24,325,773.2--106,010,223.85-106,474,954.59
四、汇率变动对现金及现金等价物的影响-5,228,009.43-1,729,883.08-40,655,864.92349,671.9
五、现金及现金等价物净增加额-99,570,231.1861,295,720.78-38,181,723.96-276,540,863.67
  加:期初现金及现金等价物余额420,101,954.19420,101,954.19458,283,678.15458,283,678.15
  期末现金及现金等价物余额320,531,723.01481,397,674.97420,101,954.19181,742,814.48
补充资料:
  净利润-10,589,492.39-69,209,771.31-
  资产减值准备1,900,464.79-8,121,508.05-
  固定资产和投资性房地产折旧20,265,228.44-41,906,321.98-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧20,265,228.44-41,906,321.98-
  无形资产摊销3,716,815.54-3,371,587.47-
  长期待摊费用摊销21,445,017.52-6,091,274.89-
  处置固定资产、无形资产和其他长期资产的损失-30,001.99--66,315.36-
  固定资产报废损失--1,215,672.97-
  公允价值变动损失-13,654,982.22--26,572,894.84-
  财务费用43,277,264.31-34,183,512.26-
  投资损失-58,772,337.02--128,208,684.84-
  递延所得税4,650,772.93-3,098,545.79-
  其中:递延所得税资产减少10,613,800.38-4,710,071.86-
    递延所得税负债增加-5,963,027.45--1,611,526.07-
  存货的减少4,758,537.21-5,407,047.94-
  经营性应收项目的减少340,363,814.35-20,125,685.12-
  经营性应付项目的增加-393,989,711.45--54,710,167.95-
  现金的期末余额320,531,723.01-420,101,954.19-
  减:现金的期初余额420,101,954.19-458,283,678.15-
  现金及现金等价物的净增加额-99,570,231.18--38,181,723.96-
公告日期2026-08-282026-04-302026-04-302025-10-31
审计意见(境内)标准无保留意见
TOP↑